Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Epigenome-wide Analysis of Asthma from The Asthma BioRepository for Integrative Genomic Exploration (Asthma BRIDGE) Project

ABSTRACT: Epigenome-wide Analysis of Asthma from The Asthma BioRepository for Integrative Genomic Exploration (Asthma BRIDGE) Project

PROVIDER: PRJNA1251651 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

Epigenome-wide Analysis of Asthma from The Asthma BioRepository for Integrative Genomic Exploration (Asthma BRIDGE) Project

Project description:Epigenetic analysis of DNA methylation for whole blood and CD4+ cell types was performed. Gene expressions were compared betweenpatients with asthma and the control groups.

2025-07-22 | GSE294810 | GEO

Transcriptomic Analysis of Asthma from The Asthma BioRepository for Integrative Genomic Exploration (Asthma BRIDGE) Project

Project description:Microarray gene expression analysis of various cell types was performed. Gene expressions were compared between patients with asthma and the control groups.

2025-01-06 | GSE285752 | GEO

Tissue Sampling and Biorepository to improve Cancer Cell Therapy

Project description:Tissue Sampling and Biorepository to improve Cancer Cell Therapy

| PRJNA909907 | ENA

Tissue Sampling and Biorepository to improve Cancer Cell Therapy

Project description:Tissue Sampling and Biorepository to improve Cancer Cell Therapy

| PRJNA909908 | ENA

Microbiome Core Asthma Blood Samples

Project description:MAP Project 25 asthma blood samples run for the UCSD Microbiome Core

2022-09-01 | MSV000090246 | MassIVE

Asthma IV

Project description:Asthma IV

| PRJNA540484 | ENA

Genome-wide profiling of an enhancer-associated histone modification reveals the influence of asthma on the epigenome of the airway epithelium.

Project description:Asthma is a chronic inflammatory disease of the airways driven by complex genetic-environmental interactions. Epigenomic mechanisms including histone modifications and DNA methylation are altered in key cell types of asthma. However, genome-wide studies of histone modifications in the airway epithelium of asthmatics have yet to be undertaken. We undertook genome-wide profiling of an enhancer (regulatory domain)-associated histone modification H3K27ac in bronchial epithelial cells (BECs) from asthmatic and healthy control individuals. We identified 49,903 (P<0.05) regions exhibiting differential H3K27ac enrichment in asthma and found they clustered predominately at genes associated with Th2-high asthma (e.g. CLCA1) and epithelial processes (e.g. EMT). We determined asthma had a dramatic influence on the enhancer landscape of BECs and identified asthma-associated Super-Enhancers encompassing genes encoding transcription factors (e.g. TP63) and enzymes involved in lipid metabolism (e.g. NOX4). We integrated published protein expression, epigenomic and transcriptomic datasets and identified epithelium-specific transcription factors associated with H3K27ac in asthma (e.g. TP73) and dynamic relationships between asthma-associated changes in H3K27ac, DNA methylation, genetic susceptibility and transcriptional profiles. Finally, using a CRISPR-based approach to recapitulate the H3K27ac landscape of asthma in vitro, we provide proof of principal that asthma-associated gene expression (e.g. SERPINB2) is driven in part by aberrant histone acetylation. This report identifies the influence of asthma on the epigenome of airway epithelium and provides evidence that aberrant epigenomic mechanisms exert functional consequences in key cell types of asthma, validating the combination of genome-wide and epigenome-editing approaches in identifying and deciphering the molecular mechanisms underlying asthma pathogenesis.

2019-06-04 | GSE109894 | GEO

Quantitative analysis of proteome dynamics in a long-term asthma mouse model

Project description:Asthma bronchiale is an inflammatory disease of the respiratory airways and a major factor of increasing health care costs worldwide. The molecular actors leading to asthma are not fully understood and require further investigation. The aim of this study was to monitor the proteome during asthma development from early inflammatory to late fibrotic stages. A time-course-based ovalbumin (OVA) mouse model was applied to establish an asthma phenotype and the lung proteome was analysed at four time points during asthma development (0 weeks = control, 5 weeks, 8 weeks and 12 weeks of OVA treatment).

2021-02-11 | PXD011159 | Pride

Epigenome analysis reveals novel aspects of ILC2 activation and supports a pathogenic role in asthma

Project description:Recent studies have shown that group 2 innate lymphoid cells (ILC2s) can drive eosinophilic airway inflammation in mouse models of asthma. Moreover, elevated ILC2 counts and/or activity have been reported in asthmatics, together suggesting that ILC2s play an important role in asthma pathophysiology. However, many aspects of ILC2 biology are not fully understood, including the mechanisms underlying ILC2 activation, the tissue-specific functions of ILC2s during inflammation (e.g. lung versus draining lymph node) and what drives ILC2 plasticity. Importantly, it is unknown whether human (epi)genetic variation associated with asthma susceptibility and persistence can be coupled to ILC2s. We address these questions in our manuscript by studying the epigenome of murine ILC2s obtained from Gata3-reporter mice with eosinophilic airway inflammation as well as human ILC2s obtained from peripheral blood and activated in vitro.

2018-03-14 | GSE98843 | GEO

Asthma metagenomics

Project description:Southmapton Asthma metagenomics

| PRJEB6465 | ENA